MicroRNAs are short RNA strands, of which more than 2,300 have been identified in humans. Their abnormal expression contributes to the development of many diseases, such as…

Academia Europaea is a European, non-governmental association acting as an Academy which covers all disciplines and invites distinguished scientists to become members based on peer review. – It is a…

Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.

A team of Doctoral Researchers are delighted to announce the BioCity PhD Mini-Symposium planned on the afternoon before the main symposium, i.e., on Wednesday 23rd August, 2023. This will be an ideal platform…

Mikael Knip of the University of Helsinki is conferred as a Turku University honorary doctor in medicine for his merits in the research of type 1 diabetes. Knip is one…

We are delighted to share the following funding news with everyone. Warmest congratulations to those who got funded. BioCity Turku Collaborative Research Funding Call Results All funded…

The EURAS consortium received Horizon funding to develop new treatments for rare neurodevelopmental disorders of the Ras pathway.

MSc Srikar Nagelli defends his dissertation in Pathology entitled “CIP2A is a critical DNA damage response protein that drives basal-like breast cancer” at the University of Turku on 14 April…

INITIALISE Minisymposium 26 April, 2023, at 8:30 am – 4:00 pm President Auditorium, Mauno Koivisto Centre, BioCity Flyer Register latest April 17th at  https://link.webropolsurveys.com/S/A2E98F4614DA0061 Minisymposium organized by the…

Registration to the 32nd BioCity Symposium is open until Friday 11 August 2023, 23:59 (CET+1) If you wish to submit a poster abstract please register at latest Friday 9…